- Home
- ADV vs OPK Comparison
ADV vs OPK Comparison
Compare ADV & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADV
- OPK
- Stock Information
- Founded
- ADV 1987
- OPK 2007
- Country
- ADV United States
- OPK United States
- Employees
- ADV N/A
- OPK N/A
- Industry
- ADV Business Services
- OPK Biotechnology: Pharmaceutical Preparations
- Sector
- ADV Consumer Discretionary
- OPK Health Care
- Exchange
- ADV Nasdaq
- OPK Nasdaq
- Market Cap
- ADV 428.1M
- OPK 1.1B
- IPO Year
- ADV N/A
- OPK 1995
- Fundamental
- Price
- ADV $1.38
- OPK $1.34
- Analyst Decision
- ADV Strong Buy
- OPK Buy
- Analyst Count
- ADV 1
- OPK 4
- Target Price
- ADV $2.50
- OPK $2.75
- AVG Volume (30 Days)
- ADV 672.6K
- OPK 3.3M
- Earning Date
- ADV 08-06-2025
- OPK 08-06-2025
- Dividend Yield
- ADV N/A
- OPK N/A
- EPS Growth
- ADV N/A
- OPK N/A
- EPS
- ADV N/A
- OPK N/A
- Revenue
- ADV $3,526,704,000.00
- OPK $689,408,000.00
- Revenue This Year
- ADV N/A
- OPK N/A
- Revenue Next Year
- ADV N/A
- OPK $6.98
- P/E Ratio
- ADV N/A
- OPK N/A
- Revenue Growth
- ADV N/A
- OPK N/A
- 52 Week Low
- ADV $1.04
- OPK $1.21
- 52 Week High
- ADV $4.16
- OPK $2.04
- Technical
- Relative Strength Index (RSI)
- ADV 50.31
- OPK 51.42
- Support Level
- ADV $1.41
- OPK $1.32
- Resistance Level
- ADV $1.67
- OPK $1.36
- Average True Range (ATR)
- ADV 0.11
- OPK 0.04
- MACD
- ADV -0.01
- OPK 0.00
- Stochastic Oscillator
- ADV 48.72
- OPK 65.38
About ADV Advantage Solutions Inc.
Advantage Solutions Inc is a omnichannel retail solutions agency in North America, uniquely positioned at the intersection of consumer-packaged goods (CPG) brands and retailers.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.